Cancer patients across Kenya are facing disruptions in treatment following changes to the Social Health Authority (SHA) approval system, with some patients reporting rejected treatment claims, reduced medication limits and increased out-of-pocket expenses. The new procedures have also raised concerns among healthcare workers over delays in accessing essential cancer drugs and diagnostic services.
The changes have introduced several approval stages, strict financial limits on medicines and diagnostic tests, and restrictions on where patients can obtain chemotherapy drugs. Patients say the new system has made it harder to access essential treatment, with some forced to pay from their pockets to avoid missing scheduled hospital appointments.
At Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), only 12 out of 30 oncology treatment requests submitted to SHA on Monday were approved, highlighting the extent of the challenges. An oncologist at the facility, who requested anonymity, said even the patients whose requests were approved had to make additional payments. One patient receiving treatment for colon cancer was forced to pay Sh20,000 for medical tests that had previously been fully covered.
The medic added that reduced coverage for diagnostic and monitoring tests was creating further difficulties, particularly for patients who depend entirely on public health insurance. The financial pressure is also affecting patients receiving medication for breast cancer. One woman said her drug allocation had been reduced to Sh5, 400, despite requiring more than Sh20,000 monthly for Letrozole, a hormone therapy used to manage certain types of breast cancer.
Delays have also increased as oncology requests must now pass through three approval stages involving a nurse, an oncologist and a pharmacist. A nurse at Kenyatta National Hospital (KNH) said the additional procedures had increased waiting times and created longer queues in oncology clinics.
The Kenya Network for Cancer Organisations has called for clarification on the new rules, particularly the restrictions on treatment facilities and financial limits.
SHA, however, says the changes are intended to standardize treatment costs and align care with national cancer guidelines. The authority maintains that patients have an enhanced annual oncology benefit of Sh800,000, comprising Sh400,000 under the Social Health Insurance Fund and another Sh400,000 under the Emergency, Chronic and Critical Illness Fund.
It says patients should not pay twice for services already covered, although additional charges may apply where treatment exceeds approved rates or falls outside the benefits package.


